A transformative study has shown that combining Endoscopic Sleeve Gastroplasty (ESG) with GLP-1 receptor agonist drugs, such semaglutide, delivers superior weight loss results compared to ESG alone. It is changing the landscape of obesity treatment.
Digestive-Disease
Read more